{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:19:57Z","timestamp":1791821997031,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-153255"],"award-info":[{"award-number":["PJT-153255"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jceh.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T18:21:27Z","timestamp":1694283687000},"page":"101280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells"],"prefix":"10.1016","volume":"14","author":[{"given":"Rajani","family":"Kandhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4868-3934","authenticated-orcid":false,"given":"Sheela","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7563-576X","authenticated-orcid":false,"given":"Subburaj","family":"Ilangumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2023.09.001_bib1","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jceh.2023.09.001_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","article-title":"Healthcare and socioeconomic costs of NAFLD: a global framework to navigate the uncertainties","volume":"79","author":"Allen","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.09.001_bib5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib6","article-title":"New targets for NAFLD","volume":"3","author":"Parlati","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2023.09.001_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.09.001_bib8","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.09.001_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040365","article-title":"Hepatic stellate cell activation and inactivation in NASH-fibrosis-roles as putative treatment targets?","volume":"9","author":"Zisser","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jceh.2023.09.001_bib10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jcmgh.2023.02.010","article-title":"Hepatic stellate cells: dictating outcome in nonalcoholic fatty liver disease","volume":"15","author":"Wiering","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.09.001_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib13","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nri818","article-title":"Suppressors of cytokine signalling (SOCS) in the immune system","volume":"2","author":"Alexander","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jceh.2023.09.001_bib15","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1007\/s00018-014-1619-y","article-title":"SOCS proteins in regulation of receptor tyrosine kinase signaling","volume":"71","author":"Kazi","year":"2014","journal-title":"Cell Mol Life Sci : CM"},{"key":"10.1016\/j.jceh.2023.09.001_bib16","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2337\/db11-0259","article-title":"Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance","volume":"60","author":"Sachithanandan","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2023.09.001_bib17","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20031675","article-title":"SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis","volume":"199","author":"Yoshida","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jceh.2023.09.001_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cyto.2015.12.007","article-title":"Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1","volume":"82","author":"Kandhi","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jceh.2023.09.001_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.07.032","article-title":"Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis","volume":"124","author":"Mafanda","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.jceh.2023.09.001_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jceh.2023.09.001_bib21","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0168-8278(14)60149-5","article-title":"O147 Hepatic stellate cells are the major source of collagen in murine models of liver fibrosis","volume":"60","author":"\u00d6sterreicher","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib22","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jceh.2023.09.001_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/ar.25039","article-title":"An improved method for isolation and flow cytometric characterization of intrahepatic leukocytes from fatty and fibrotic liver tissues","volume":"306","author":"Kandhi","year":"2023","journal-title":"Anat Rec"},{"key":"10.1016\/j.jceh.2023.09.001_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","article-title":"Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice","volume":"45","author":"Czochra","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111419","article-title":"TGF-Beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jceh.2023.09.001_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ni931","article-title":"SOCS3 negatively regulates IL-6 signaling in\u00a0vivo","volume":"4","author":"Croker","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jceh.2023.09.001_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jceh.2023.09.001_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jceh.2023.09.001_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-dependent mechanisms of hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.09.001_bib30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/rth2.12403","article-title":"Liver fibrosis is driven by protease-activated receptor-1 expressed by hepatic stellate cells in experimental chronic liver injury","volume":"4","author":"Poole","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jceh.2023.09.001_bib31","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2020.01.027","article-title":"Identification of lineage-specific transcription factors that prevent activation of hepatic stellate cells and promote fibrosis resolution","volume":"158","author":"Liu","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.09.001_bib32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2023.09.001_bib33","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1038\/s41598-023-34353-y","article-title":"An inducible model for genetic manipulation and fate-tracing of PDGFRbeta-expressing fibrogenic cells in the liver","volume":"13","author":"Hamberger","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2023.09.001_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.510310123","article-title":"Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice","volume":"31","author":"Kovalovich","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.09.001_bib35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2004.11.043","article-title":"Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis\u00a0in mice by reducing MMP-2 expression","volume":"42","author":"Bansal","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176173","article-title":"Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation","volume":"12","author":"Kagan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2023.09.001_bib37","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1038\/onc.2015.20","article-title":"Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma","volume":"34","author":"Gui","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.jceh.2023.09.001_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","article-title":"Regulation of PDGF and its receptors in fibrotic diseases","volume":"15","author":"Bonner","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jceh.2023.09.001_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","article-title":"beta-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis","volume":"63","author":"Kocabayoglu","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib40","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/emboj\/18.4.904","article-title":"Socs1 binds to multiple signalling proteins and suppresses steel factor- dependent proliferation","volume":"18","author":"De Sepulveda","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.jceh.2023.09.001_bib41","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1091\/mbc.e05-02-0149","article-title":"Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization","volume":"16","author":"Uemura","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jceh.2023.09.001_bib42","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","article-title":"Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 Axis to induce hepatic fibrosis in coordination with the SMAD pathway","volume":"292","author":"Tang","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2023.09.001_bib43","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jceh.2023.09.001_bib44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(02)00446-6","article-title":"SOCS1\/JAB is a negative regulator of LPS-induced macrophage activation","volume":"17","author":"Kinjyo","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.jceh.2023.09.001_bib45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ni1299","article-title":"Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation","volume":"7","author":"Mansell","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jceh.2023.09.001_bib46","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1096\/fj.10-170597","article-title":"Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus","volume":"25","author":"Strebovsky","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.jceh.2023.09.001_bib47","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1038\/s41598-018-25699-9","article-title":"Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2023.09.001_bib48","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.09.001_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.867940","article-title":"Hepatic stellate cell-immune interactions in NASH","volume":"13","author":"Carter","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jceh.2023.09.001_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.31743","article-title":"Heterogeneity of HSCs in a mouse model of NASH","volume":"74","author":"Rosenthal","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.09.001_bib51","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/hep.27680","article-title":"Nonalcoholic fatty liver disease: fibrosis portends a worse prognosis","volume":"61","author":"Torres","year":"2015","journal-title":"Hepatology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323007016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323007016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:11:29Z","timestamp":1760854289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688323007016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0973688323007016"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2023.09.001","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101280"}}